palmidrol has been researched along with Fibromyalgia in 4 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salaffi, F | 1 |
| Farah, S | 1 |
| Sarzi-Puttini, P | 2 |
| Di Carlo, M | 1 |
| Stensson, N | 2 |
| Gerdle, B | 2 |
| Ernberg, M | 1 |
| Mannerkorpi, K | 1 |
| Kosek, E | 1 |
| Ghafouri, B | 2 |
| Ghafouri, N | 1 |
| Schweiger, V | 1 |
| Martini, A | 1 |
| Bellamoli, P | 1 |
| Donadello, K | 1 |
| Schievano, C | 1 |
| Balzo, GD | 1 |
| Parolini, M | 1 |
| Polati, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Training and Relaxation on Fibromyalgia.[NCT01226784] | 240 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Efficacy and Tolerability of Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients: A Double-blind, Randomized, Placebo-controlled Clinical Trial[NCT04488926] | Phase 4 | 21 participants (Actual) | Interventional | 2020-07-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for palmidrol and Fibromyalgia
| Article | Year |
|---|---|
Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study.
Topics: Acetylcarnitine; Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pregabalin; Treat | 2023 |
3 other studies available for palmidrol and Fibromyalgia
| Article | Year |
|---|---|
Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia.
Topics: Amides; Anxiety; Arachidonic Acids; Depression; Endocannabinoids; Ethanolamines; Exercise Therapy; F | 2020 |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study.
Topics: Adult; Aged; Amides; Anti-Inflammatory Agents; Chronic Pain; Cytokines; Endocannabinoids; Ethanolami | 2017 |
Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients.
Topics: Adult; Amides; Ethanolamines; Female; Fibromyalgia; Humans; Italy; Male; Middle Aged; Pain Measureme | 2019 |